Resultats de la cerca - David Rizzeri

  • Mostrar 1 - 2 resultats de 2
Refinar resultats
  1. 1
    Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML

    Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML per Jorge E. Cortés, Stuart L. Goldberg, Eric J. Feldman, David Rizzeri, Donna E. Hogge, Melissa L. Larson, Arnaud Pigneux, Christian Récher, Gary J. Schiller, Krzysztof Warzocha, Hagop M. Kantarjian, Arthur C. Louie, Jonathan E. Kolitz

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia

    An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia per Jeevisha Bajaj, Michael Hamilton, Yutaka Shima, Kendall R. Chambers, Kyle Spinler, Eric L. Van Nostrand, Brian A. Yee, Steven M. Blue, Michael Chen, David Rizzeri, Charles Chuah, Vivian G. Oehler, H. Elizabeth Broome, Roman Šášik, James Scott‐Browne, Anjana Rao, G Yeo, Tannishtha Reya

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: